Literature DB >> 12543267

Polycyclic phenols, estrogens and neuroprotection: a proposed mitochondrial mechanism.

J A Dykens1, J W Simpkins, J Wang, K Gordon.   

Abstract

Polycyclic phenols, including the estrogens, have been shown to be potent neuroprotectants in a variety of cellular and animal model systems. Although classical estrogen receptor interactions and consequent responses play a role in certain circumstances, the neuroprotective activity of polycyclic phenols that do not interact with estrogen receptors ERalpha or ERbeta is more likely to be through non-genomic mechanism(s). We propose here that such non-feminizing polycyclic phenols exert their protective effects at least in part by stabilizing mitochondria, preventing apoptotic and/or necrotic forms of cell death that are associated with mitochondrial dysfunction. Consistent with this mitochondrial model and the available data, these compounds protect neurons and other cell types from a wide variety of pathologically relevant stressors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12543267     DOI: 10.1016/s0531-5565(02)00162-6

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  10 in total

Review 1.  Sex-dependent mental illnesses and mitochondria.

Authors:  Akiko Shimamoto; Virginie Rappeneau
Journal:  Schizophr Res       Date:  2017-03-06       Impact factor: 4.939

Review 2.  Estrogens as neuroprotectants: Estrogenic actions in the context of cognitive aging and brain injury.

Authors:  E B Engler-Chiurazzi; C M Brown; J M Povroznik; J W Simpkins
Journal:  Prog Neurobiol       Date:  2016-02-15       Impact factor: 11.685

3.  Menopause and mitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy.

Authors:  Victor W Henderson; Roberta Diaz Brinton
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

Review 4.  Does phytoestrogen supplementation affect cognition differentially in males and females?

Authors:  Nathalie Sumien; Kiran Chaudhari; Akram Sidhu; Michael J Forster
Journal:  Brain Res       Date:  2013-02-13       Impact factor: 3.252

5.  Modulation of mitochondrial Ca(2+) uptake by estrogen receptor agonists and antagonists.

Authors:  Carmen D Lobatón; Laura Vay; Esther Hernández-Sanmiguel; Jaime Santodomingo; Alfredo Moreno; Mayte Montero; Javier Alvarez
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

6.  Neuroprotective actions of selective estrogen receptor modulators.

Authors:  Lydia L DonCarlos; Iñigo Azcoitia; Luis M Garcia-Segura
Journal:  Psychoneuroendocrinology       Date:  2009-12       Impact factor: 4.905

Review 7.  Estrogen actions on mitochondria--physiological and pathological implications.

Authors:  James W Simpkins; Shao-Hua Yang; Saumyendra N Sarkar; Virginia Pearce
Journal:  Mol Cell Endocrinol       Date:  2008-05-02       Impact factor: 4.102

8.  The potential for estrogens in preventing Alzheimer's disease and vascular dementia.

Authors:  James W Simpkins; Evelyn Perez; Xiaofei Wang; Shaohua Yang; Yi Wen; Meharvan Singh
Journal:  Ther Adv Neurol Disord       Date:  2009-01       Impact factor: 6.570

Review 9.  Role of protein phosphatases and mitochondria in the neuroprotective effects of estrogens.

Authors:  James W Simpkins; Kun Don Yi; Shao-Hua Yang
Journal:  Front Neuroendocrinol       Date:  2009-05-03       Impact factor: 8.606

10.  Estrogen Signaling Induces Mitochondrial Dysfunction-Associated Autophagy and Senescence in Breast Cancer Cells.

Authors:  Khuloud Bajbouj; Jasmin Shafarin; Jalal Taneera; Mawieh Hamad
Journal:  Biology (Basel)       Date:  2020-04-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.